Recombinant DNA Technology Market size was valued at US$ 35.84 Bn in 2023 and the Medical segment dominated the growth of the Recombinant DNA Technology Market.
Recombinant DNA Technology Market Overview:
Recombinant DNA (rDNA) is a method that uses enzymes to cut and paste specific DNA sequences. The reassembled DNA sequences can be transferred to an appropriate host cell for replication or expression by inserting them into vectors. Human proteins like growth hormone and insulin, which are used in disease treatment, have been effectively produced in bacteria through the use of recombinant DNA technology.
Click here for a sample report link:
Recombinant DNA Technology Market Dynamics:
Recombinant DNA (rDNA) technology has given scientists unprecedented control over genetic material. This has made it possible for it to be employed in a variety of classic and non-traditional applications. The production of recombinant drugs and treatments without the need for human donors has advanced significantly in recent years. One common example of this achievement is the commercial success of genetically engineered insulin for the treatment of diabetes. Biotech and pharma businesses are exploring the possibilities of rDNA methods in several parts of sickness treatment.
Market Scope:
The report's goal is to provide industry stakeholders with a thorough study of the recombinant DNA technology market. The research presents the industry's historical and present state together with projected market size and trends, analyzing complex data in an easy-to-read manner. The study includes a thorough analysis of important competitors, including market leaders, followers, and recent entrants, and it covers every facet of the industry.
Segmentation:
by Product
Medical
Therapeutic Agent
Human Protein
Vaccine
Non-medical
Biotech Crops
Specialty Chemicals
Others
by Component
Expression System
Mammalian
Bacteria
Yeast
Baculovirus / insect
Others
Cloning Vector
by Application
Food & Agriculture
Health & Disease
Human
Animal
Environment
Others
by End-User
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Key Players:
The research presents a competitive landscape through an in-depth examination of significant strategic developments undertaken by key market players in the Recombinant DNA Technology sector over time. The leading players in the global Recombinant DNA Technology market include:
1. F. Hoffmann-La Roche Ltd (Genentech, Inc)
2. Profacgen
3. Amgen Inc
4. Novartis AG
5. GenScript
6. Pfizer Inc
7. Novo Nordisk A/S
8. Eli Lilly and Company
9. Sanofi
10. Merck & Co., Inc.
11. Biogen
12. Biocon
13. GlaxoSmithKline plc
14. New England Biolabs.
15. Cibus
16. Monsanto Company
17. Horizon Discovery Group PLC
Know more about the detailed report:
Regional Analysis:
North America: (Canada, Mexico, and the United States)
Europe (including Russia, the UK, France, Germany, Italy, Spain, Sweden, Austria, and Turkey)
Asia Pacific includes ASEAN, Australia, South Korea, Japan, China, India, and the rest of the region.
Africa and the Middle East (South Africa, GCC, Egypt, Nigeria, and the Remainder of ME&A)
South America (Argentina, Brazil, Columbia, and Other South American Countries)
More Related Report:
Global Active Pharmaceutical Ingredients CDMO Market
Global Recombinant DNA Technology Market
COVID-19 Impact Analysis on the Market:
The increase in COVID-19 cases has led to a large growth in the market for Recombinant DNA Technologyes. The vast amounts of data generated by social media platforms, the rising trends in cloud computing, and the high uptake of these solutions by small and medium-sized businesses present a wealth of opportunities for providers of Recombinant DNA Technology solutions. The growth of the industry is, however, constrained by legislation, conflicting standards, difficulties with management workflow, and regulatory and compliance requirements. The lack of defined procedures for systems of Recombinant DNA Technologyes as well as a comprehensive solution to deal with the growing problems related to unstructured data may hinder this market's growth.
Key Questions Answered in the Recombinant DNA Technology Market Report:
What level of competition is there in the market for Recombinant DNA Technologyes?
What are the main drivers of the Recombinant DNA Technology market's expansion?
Which area of the Recombinant DNA Technology market has the biggest share?
What will the recombinant DNA technology market's compound annual growth rate be between 2024 and 2030?
About Us
One of the fastest-growing business consulting and market research companies in the world, Maximize Market Research serves clients all over the world. Most Fortune 500 organizations are happy to have us as a partner because of our revenue impact and targeted, growth-driven research projects. We service a wide range of industries, including food and beverage, chemicals, IT & telecom, aerospace & defense, healthcare, and others. Our portfolio is broad.
Our Address
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune-Banglore Highway, Narhe
Pune, Maharashtra, 411041, India.
✆ +91 9607365656
? sales@maximizemarketresearch.com
? www.maximizemarketresearch.com
